While the significant $730 million acquisition of dental leader ZimVie from Archimed stole the spotlight this week, funding activity has not dried up even in the peak of summer. It’s been a strong week for dental, with vVardis closing a $50m round, while orthopaedics and oncology companies securing funding too. Get the details in our GS MedTech Funding Tracker.
vVardis closes $50m funding for their Curodont dental treatment
After acquiring an initial 35 million from healthcare investment firm OrbiMed in February 2025, a follow-up funding round that recently closed produced an additional $50 million. The total capital of $85 million will be used to continue the global commercial expansion of innovative dental products under the Curodont brand.
As partners, vVARDIS and OrbiMed have a shared vision to address this epidemic by becoming a US and global leader in innovative dental products. Nearly 10% of US practices have purchased the product, enabling the treatment of 400,000 patients since 2024.
Founders and co-CEOs Drs. Haley and Goly Abivardi
Last week’s tracker, GT Medical and more
Shoulder Innovations closes $40m financing
The convertible notes financing was led by new investor Fidelity Management & Research Company. The proceeds will be used primarily to support continued commercialisation of Shoulder Innovations’ advanced implant systems for anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA), as well as for new product development.
Both implant systems leverage consistent surgical techniques and the same efficient, two tray instrumentation system.
CEO Rob Ball
Cooler Heads secures $11m to expand rollout of Portable Scalp Cooling System
The company closed an oversubscribed $11 million Series A funding round to expand the manufacturing and rollout of Amma, the only FDA-cleared Portable Scalp Cooling System.
The round was led by Mutual Capital Partners, a Cleveland healthtech-focused venture capital fund, and contained participation from SHD Partners, Crescent Ridge VC, Cal Innovation Fund, NuFund, Robin Hood Ventures, Golden Seeds, HIP VC, and an unnamed strategic investor.
CEO and founder Kate Dilligan
HeartLab closed $2 million in seed funding
The new funding brings the total value to $8 million. The New Zealand-headquartered startup’s cloud-based platform streamlines the entire echocardiography workflow for cardiology teams.
Investors included research scientist and cardiologist David Ouyang from Kaiser Permanente. In 2021, the company closed $3.5 million in a funding round led by Peter Thiel’s Founders Fund, supported by Icehouse Ventures, Outset Ventures and private investor Dylan Field.
CEO Will Hewitt
Medyria secures investment of 1.5 million Swiss francs
The funding was led by the Lisbon-based Portuguese subsidiary of Madrid-based venture capital fund Buenavista. Existing investors also participated.
The funds will be used to initiate the first clinical trials in humans of the next generation of microcatheters for invasive cardiological diagnosis.
CEO Mauro M. Sette
